A case of acute promyelocytic leukemia variant with derivative chromosome 3 der(3)t(3;8) associated with 8q partial gain

[1]  F. Lo‐Coco,et al.  Molecular remission as a therapeutic objective in acute promyelocytic leukemia , 2018, Leukemia.

[2]  C. Tirado,et al.  A t(3;8)(q26.2;q24) involving the EVI1 (MECOM) Gene. , 2018, Journal of the Association of Genetic Technologists.

[3]  P. Pandolfi,et al.  Acute Promyelocytic Leukemia: A Paradigm for Oncoprotein-Targeted Cure. , 2017, Cancer cell.

[4]  R. Das,et al.  Isolated Central Nervous System (CNS) Relapse in Paediatric Acute Promyelocytic Leukaemia: A Systematic Review. , 2017, Journal of clinical and diagnostic research : JCDR.

[5]  Mario Cazzola,et al.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. , 2016, Blood.

[6]  F. Lo‐Coco,et al.  Current management of newly diagnosed acute promyelocytic leukemia. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[7]  T. Yamane,et al.  Therapy-related myelodysplastic syndrome: a case study. , 2015, American journal of blood research.

[8]  T. Haferlach,et al.  AML with gain of chromosome 8 as the sole chromosomal abnormality (+8sole) is associated with a specific molecular mutation pattern including ASXL1 mutations in 46.8% of the patients. , 2015, Leukemia research.

[9]  D. Douer,et al.  Extramedullary disease in APL: a real phenomenon to contend with or not? , 2014, Best practice & research. Clinical haematology.

[10]  S. Lowe,et al.  Gain of MYC underlies recurrent trisomy of the MYC chromosome in acute promyelocytic leukemia , 2010, The Journal of experimental medicine.

[11]  R. Hills,et al.  Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. , 2010, Blood.

[12]  Holly M Knoderer,et al.  Central nervous system involvement at the time of presentation in acute promyelocytic leukemia , 2010, Pediatric blood & cancer.

[13]  V. Cóser,et al.  External auditory canal and middle ear relapse of acute promyelocytic leukemia treated with arsenic trioxide: case report and review of the literature. , 2010, Journal of pediatric hematology/oncology.

[14]  G. Terzoudi,et al.  Isochromosome der(17)(q10)t(15;17) in Acute Promyelocytic Leukemia Resulting in an Additional Copy of the RARA-PML Fusion Gene: Report of 4 Cases and Review of the Literature , 2010, Acta Haematologica.

[15]  M. Tormo,et al.  Additional chromosome abnormalities in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy , 2010, Haematologica.

[16]  C. Bloomfield,et al.  The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. , 2009, Blood.

[17]  Z. Estrov,et al.  Incidence of extramedullary disease in patients with acute promyelocytic leukemia: a single-institution experience , 2009, International journal of hematology.

[18]  H. Dombret,et al.  Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy , 2006, Leukemia.

[19]  R. Gershoni-baruch,et al.  Derivative (7)t(7;8)(q34;q21): an additional chromosome aberration in acute promyelocytic leukemia-prognostic influence debated. , 2004, Cancer genetics and cytogenetics.

[20]  Keun-Wook Lee,et al.  Extramedullary Relapse Confirmed by Fluorescence In Situ Hybridization Study of an Ear Mass in Acute Promyelocytic Leukemia , 2004, International journal of hematology.

[21]  F. Mandelli,et al.  Early detection of meningeal localization in acute promyelocytic leukaemia patients with high presenting leucocyte count , 2003, British journal of haematology.

[22]  J. Vial,et al.  Derivative (7)t(7;8)(q34;q21). a new additional cytogenetic abnormality in acute promyelocytic leukemia. , 2003, Cancer genetics and cytogenetics.

[23]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[24]  G. Specchia,et al.  Ear involvement in acute promyelocytic leukemia at relapse: a disease-associated ‘sanctuary’? , 2002, Leukemia.

[25]  M. L. Le Beau,et al.  Recurring chromosomal abnormalities in leukemia in PML-RARA transgenic mice parallel human acute promyelocytic leukemia. , 2002, Blood.

[26]  M. Vignetti,et al.  Extramedullary involvement at relapse in acute promyelocytic leukemia patients treated or not with all-trans retinoic acid: a report by the Gruppo Italiano Malattie Ematologiche dell'Adulto. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  G. Ooi,et al.  Unusual sites of involvement by hematologic malignancies. Case 3. External auditory canal tumor: a rare chloroma in acute promyelocytic leukemia with a complete response to arsenic trioxide. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  J. Cervera,et al.  Cutaneous promyelocytic sarcoma at sites of vascular access and marrow aspiration. A characteristic localization of chloromas in acute promyelocytic leukemia? , 2000, Haematologica.

[29]  Y. Yuan,et al.  A rare variant translocation t(3;8)(q29;q22) without AML1/ETO fusion transcript in a case of oligoblastic leukemia. , 1998, Leukemia research.

[30]  A. Biondi,et al.  Extramedullary involvement in patients with acute promyelocytic leukemia , 1998, Cancer.

[31]  R. Ohno,et al.  Relapse in the external auditory canal of acute promyelocytic leukemia after treatment with all-trans retinoic acid. , 1997, Internal medicine.